Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cance...
Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers
About this item
Full title
Author / Creator
Publisher
England: BioMed Central
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central
Subjects
More information
Scope and Contents
Contents
The aim of this study was to investigate the expression of the nuclear receptor PPARγ, together with that of the cyclooxygenases Cox-1 and Cox-2, in breast cancer (BC) tissues and to correlate the data with several clinicobiological parameters including patient survival.
In a well characterized cohort of 308 primary BC, PPARγ, Cox-1 and Cox-2 cy...
Alternative Titles
Full title
Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_26accad62b804d7fb3ece1e264920c11
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_26accad62b804d7fb3ece1e264920c11
Other Identifiers
ISSN
1479-5876
E-ISSN
1479-5876
DOI
10.1186/s12967-020-02271-6
